Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest kidney transplant Stories

2012-03-07 05:25:00

HORSHOLM, Denmark, March 7, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) ('Veloxis') today published the annual report of Veloxis Pharmaceuticals A/S for the financial year 2011. The annual report has been prepared in accordance with International Financial Reporting Standards as adopted by the EU and additional Danish disclosure requirements for annual reports of listed companies. This company announcement should be read in conjunction with Veloxis' annual report 2011...

2012-02-17 11:02:20

Classes spur patients to get evaluated for a kidney transplant Highlights     Kidney transplantation is the preferred treatment for kidney failure patients, but blacks are less likely to receive kidney transplants than whites.     Kidney failure patients–particularly blacks and those living in poor neighborhoods–who take part in an education program are more likely to get evaluated for a kidney transplant.     Requiring a formal...

2012-01-27 11:24:48

Stopping immunosuppressive prednisone soon after transplantation found safe Highlights:     Patients who quickly stop taking the immunosuppressant prednisone after receiving a kidney transplant avoid experiencing serious prednisone-related side effects.     This rapid discontinuation of prednisone does not jeopardize the long-term survival of patients and their new organs.     Approximately 16,500 patients receive kidney transplants each...

2012-01-12 20:54:06

Thousands more American senior citizens with kidney disease are good candidates for transplants and could get them if physicians would get past outdated medical biases and put them on transplant waiting lists, according to a new study by Johns Hopkins researchers. The Hopkins investigators estimate that between 1999 and 2006, roughly 9,000 adults over 65 would have been "excellent" transplant candidates and approximately 40,000 more older adults would have been "good" candidates for new...

2012-01-04 07:00:00

HORSHOLM, Denmark, Jan. 4, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in the STRATO (Switching kidney TRAnsplant patients with Tremor to LCP-tacrO) Phase IIIb study of LCP-Tacro(TM) in kidney transplant recipients experiencing drug-induced tremors. The STRATO study is designed to explore whether a conversion of patients who have symptomatic tremor from treatment with standard immediate release twice-daily tacrolimus capsules to...

2011-12-23 08:58:26

Anemia drugs prevent many transplanted kidneys from failing Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that aggressively treating anemia may help save the kidneys–and possibly the lives–of many transplant recipients. Anemia commonly arises in patients with kidney disease...

2011-11-16 07:32:48

Head to Head: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? With three people on the kidney transplant list dying in the UK every day, should doctors encourage their patients to put themselves at risk for the benefit of others? Two experts debate the issue on bmj.com today. Associate Professor Walter Glannon from the University of Calgary argues that, although living kidney donation is relatively safe, "this does not imply that doctors should...

2011-11-10 15:37:05

Kids of minority races less likely to get a kidney transplant before needing dialysis; Blacks with no health insurance more likely to die while waiting for a transplant Highlights:     Pediatric racial minorities are much less likely than whites to get kidney transplants before they need dialysis, regardless of their families' income.     Among children with kidney failure waiting for a transplant, blacks with no health insurance are more likely to die...

2011-11-08 07:00:00

LAWRENCE, Mass., Nov. 8, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One(TM) patient David RUSH, 29, is celebrating the one-year anniversary of his successful kidney transplant during a special event on November 9, 2011. RUSH received the transplant following more than two years of more frequent home hemodialysis with the System One....

2011-09-06 06:00:00

HORSHOLM, Denmark, Sept. 6, 2011 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), formerly LifeCycle Pharma, today announced that efficacy results from its Phase 3 study in stable kidney transplant patients suggests that its once-daily LCP-Tacro(TM) is non-inferior in efficacy compared to twice-daily standard tacrolimus tablets (Prograf®). Data will be presented in a rapid oral and poster presentation at 4:08 p.m. BST, Tuesday, Sept. 6, at the 15th Congress of the...